Research
Hormonal
Ramipril also showed a relative risk of 0.56 for the initiation of glucose-lowering therapy.
This indicates that ramipril may reduce the need for glucose-lowering medications in high-risk patients.
StrongSupportsmedium confidence
For initiation of glucose-lowering therapy, 0.56 (95% CI, 0.41-0.77).
Why this rating
Based on a large randomized controlled trial design.
Source
Ramipril and the Development of Diabetes
Salim Yusuf · JAMA · 2001
rct · n=5720Cited 546×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →